360PSystemic therapy in second-line metastatic triple negative breast cancer (mTNBC): A systematic literature review (SLR) and meta-analysis (MA) of efficacy
Abstract Background Triple negative breast cancer carries a poor prognosis. Cytotoxic chemotherapy (chemo) is the standard of care. Recent data demonstrate that immunotherapy and anti-body drug conjugate based therapy can improve outcomes. Nevertheless survival remains poor. This SLR and MA was perf...
Saved in:
Published in | Annals of oncology Vol. 30; no. Supplement_5 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford University Press
01.10.2019
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!